LANTHEUS HOLDINGS, INC. (LNTH) — financial distillation

S&P 400 · United States · Nasdaq

LNTHCIK 0001521036Period ends 2026-06-30Distilled SEC EDGAR XBRL company facts

Annual history (10-K)

Quarterly history (10-Q)

Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.

In brief, from the full filed history

  • Revenue grew from $283.7M (period ending 2013-12-31) to $1.54B (period ending 2025-12-31) — a 15.1% annual pace across 12 year(s) of filed history.
  • Net margin compressed from 37.2% to 15.2% over that same span.
  • Across 37 tracked quarters, the strongest was $394.1M (quarter ending 2024-06-30) and the weakest was $66.0M (quarter ending 2020-06-30).

Annual — most recent 10-K

Line Value Period ends Form Filing
Revenue $1.54B 2025-12-31 10-K 0001193125-26-073498
Gross profit $942.0M 2025-12-31 10-K 0001193125-26-073498
Operating income $310.8M 2025-12-31 10-K 0001193125-26-073498
Net income $233.6M 2025-12-31 10-K 0001193125-26-073498
Diluted EPS $3.41 2025-12-31 10-K 0001193125-26-073498
Total assets $2.23B 2025-12-31 10-K 0001193125-26-073498
Total liabilities $1.14B 2025-12-31 10-K 0001193125-26-073498
Cash & equivalents $359.1M 2025-12-31 10-K 0001193125-26-073498
Operating cash flow $390.1M 2025-12-31 10-K 0001193125-26-073498

Quarterly — most recent 10-Q

Line Value Period ends Form Filing
Revenue $388.2M 2026-06-30 10-Q 0001193125-26-336795
Gross profit $241.9M 2026-06-30 10-Q 0001193125-26-336795
Operating income $100.2M 2026-06-30 10-Q 0001193125-26-336795
Net income $75.0M 2026-06-30 10-Q 0001193125-26-336795
Diluted EPS $1.11 2026-06-30 10-Q 0001193125-26-336795
Total assets $2.41B 2026-06-30 10-Q 0001193125-26-336795
Total liabilities $1.10B 2026-06-30 10-Q 0001193125-26-336795
Cash & equivalents $593.3M 2026-06-30 10-Q 0001193125-26-336795
Operating cash flow $125.1M 2026-03-31 10-Q 0001193125-26-210373

Reading

The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.

Lantheus Holdings, Inc. (LNTH) operates in the medical imaging sector, with a substantial scale evident from its $1.54 billion annual revenue as of 2025-12-31 and $2.23 billion total assets. The company’s multi-year trajectory reveals robust growth, with revenue expanding at an impressive 15.1% annual pace over the past twelve years, from $283.7 million in 2013 to $1.54 billion in 2025. However, this growth has come alongside a compression of net margin, which fell from 37.2% to 15.2% during the same period.

In terms of financial performance, Lantheus demonstrates strong operating income and gross profit margins, with $942 million in gross profit and $310.8 million in operating income for the year ending 2025-12-31. The company’s net income also improved significantly from a loss of $71.3 million in 2021 to $233.6 million in 2025, and diluted EPS grew from $0.48 in 2021 to $3.41 in 2025. Cash and equivalents have increased from $359.1 million in 2025 to $593.3 million as of the most recent quarter, indicating a healthy liquidity position.

In monitoring Lantheus Holdings’ future performance, investors should pay attention to revenue trends and margin stability. The company’s history shows periods of strong growth but also highlights the importance of managing net margins amidst expansion. In upcoming filings, it will be crucial to observe whether LNTH can sustain its revenue momentum while improving or stabilizing profitability levels.


Source: SEC EDGAR company facts for CIK 0001521036 · filings index